atorvastatin pfizer 40 mg film coated tablets
pfizer ireland pharmaceuticals - atorvastatin calcium - film-coated tablet - 40 milligram(s) - hmg coa reductase inhibitors; atorvastatin
pfizer (australia) sodium chloride 0.9% (900mg/100ml) iv infusion
pfizer australia pty ltd - sodium chloride, quantity: 900 mg - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - for the restoration and maintenance of salt and extracellular fluid levels or as a vehicle for the administration of parenteral drugs.
pfizer (australia) glucose intravenous infusion bp 5% glucose (as monohydrate) 5g/100 ml injection for infusion vial
pfizer australia pty ltd - glucose monohydrate, quantity: 54.99 mg/ml (equivalent: glucose, qty 50 mg/ml) - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 31 july 2000: for fluid and carbohydrate depletion wherever a non-electrolyte fluid is required. in the treatment of hypoglycaemia. in the treatment of acute diarrhoeal disease. as a vehicle for the administration of other medications.
pfizer (australia) bupivacaine hydrochloride 0.5% (50mg/10ml) injection bp ampoule
pfizer australia pty ltd - bupivacaine hydrochloride monohydrate, quantity: 52.7 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide; hydrochloric acid - bupivacaine injection is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia - epidural block for surgery - field block (minor and major nerve blocks and infiltration). analgesia - continuous epidural infusion or intermittent bolus epidural administration for analgesia in post operative pain or labour pain. - field block (minor nerve block amd infiltration). the choice of 2 strengths, 0.25% and 0.5%, makes it possible to vary the degree of motor blockade.
pfizer (australia) sodium chloride 0.9% (450mg/50ml) intravenous infusion
pfizer australia pty ltd - sodium chloride, quantity: 450 mg - injection, intravenous infusion - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - for the restoration and maintenance of salt and extracellular fluid levels or as a vehicle for the administration of parenteral drugs.
premia 2.5 continuous
pfizer new zealand limited - conjugated estrogens 0.625mg (15mg as a dessication with lactose, includes 3% overage.); ; medroxyprogesterone acetate 2.6mg (includes 4% overage.); conjugated estrogens 0.625mg (15mg as a dessication with lactose, includes 3% overage.); medroxyprogesterone acetate 2.6mg (includes 4% overage.) - tablet - active: conjugated estrogens 0.625mg (15mg as a dessication with lactose, includes 3% overage.) medroxyprogesterone acetate 2.6mg (includes 4% overage.) excipient: calcium sulfate carnauba wax glyceryl mono-oleate iron oxide red lactose monohydrate macrogol 20000 magnesium stearate methylcellulose microcrystalline cellulose opacode black s-8-27741 povidone shellac stearic acid sucrose titanium dioxide active: conjugated estrogens 0.625mg (15mg as a dessication with lactose, includes 3% overage.) medroxyprogesterone acetate 2.6mg (includes 4% overage.) excipient: calcium sulfate carnauba wax glyceryl mono-oleate iron oxide red lactose monohydrate macrogol 20000 magnesium stearate methylcellulose microcrystalline cellulose opacode black s-8-27741 povidone shellac stearic acid sucrose titanium dioxide
premia 5 continuous
pfizer new zealand limited - conjugated estrogens 0.625mg (15mg as a dessication with lactose. includes 3% overage.); ; medroxyprogesterone acetate 5mg (includes 4% overage); conjugated estrogens 0.625mg (15mg as a dessication with lactose. includes 3% overage.); medroxyprogesterone acetate 5mg (includes 4% overage) - tablet - active: conjugated estrogens 0.625mg (15mg as a dessication with lactose. includes 3% overage.) medroxyprogesterone acetate 5mg (includes 4% overage) excipient: calcium sulfate carnauba wax glyceryl mono-oleate iron oxide red lactose monohydrate macrogols magnesium stearate methylcellulose microcrystalline cellulose opacode black s-8-27741 povidone shellac stearic acid sucrose titanium dioxide active: conjugated estrogens 0.625mg (15mg as a dessication with lactose. includes 3% overage.) medroxyprogesterone acetate 5mg (includes 4% overage) excipient: calcium sulfate carnauba wax glyceryl mono-oleate indigo carmine lactose monohydrate macrogols magnesium stearate methylcellulose microcrystalline cellulose opacode black s-8-27741 povidone shellac stearic acid sucrose titanium dioxide
atorvastatin pfizer 80 mg film coated tablets
pfizer ireland pharmaceuticals - atorvastatin calcium - film-coated tablet - 80 milligram(s) - hmg coa reductase inhibitors; atorvastatin
atorvastatin pfizer 10 mg film coated tablets
pfizer ireland pharmaceuticals - atorvastatin calcium - film-coated tablet - 10 milligram(s) - hmg coa reductase inhibitors; atorvastatin
atorvastatin pfizer 20 mg film coated tablets
pfizer ireland pharmaceuticals - atorvastatin calcium - film-coated tablet - 20 milligram(s) - hmg coa reductase inhibitors; atorvastatin